LGALS3 and Hyperglycemia: Glycotoxicity, which occurs as a result of more pronounced post-prandial hyperglycemia, is more expressed in the group of mice with transgenically enhanced galectin 3 expression, which further leads to β-cell damage and reduces the number of remaining healthy β cells compared to WT control mice on HFD (49–51).